EUVIMEDEUVIMED entdecken
Crossref

The role of the vascular surgeon in transcatheter aortic valve implantation

Enrico Gallitto iD, Gianluca Faggioli, Francesco Saia, Tullio Palmerini, Rodolfo Pini iD, Antonio Giulio Bruno, Francesca Maria Feroldi iD, Moad Alaidroos, Gabriele Ghetti, Nevio Taglieri, Stefania Caputo, Francesco Donati und 2 weitere

Vascular · 2025

DOI: 10.1177/17085381241237844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular, 2025. Verfasst von Enrico Gallitto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Surgery, Department of Experimental, Diagnostic and Specialty Medicine, IRCCS Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna,…. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Surgeons, Femoral Artery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transcatheter aortic valve implantation (TAVI) has become the standard treatment for severe aortic valve stenosis in patients at increased surgical risk. Percutaneous transfemoral (TF) is the access of choice due to its reduced invasiveness and perioperative morbidity/mortality compared with the trans-axillary, aortic, and apical routes. On the other hand, vascular access complications (VACs) of the TF access are associated with prolonged hospitalization, 30-day, and 1-year mortality. In addition, the concomitance of peripheral arterial disease may require associated endovascular management. A multidisciplinary team with Interventional Cardiologists and Vascular Surgeons may minimize the rate of VACs in patients with challenging femoral-iliac access or concomitant disease of other vascular districts, thus optimizing the outcome of TF-TAVI. The aim of this study was to evaluate the role of Vascular Surgeons in TF TAVI procedures.

Methods

We conducted a retrospective single-center review of all TF-TAVI procedures assisted by Vascular Surgeons between January 2016 and December 2020 in a high-volume tertiary hospital. Pre, intra, and postoperative data were analyzed by a dedicated group of Interventional Cardiologists and Vascular Surgeons. VACs were defined according with the Valve Academic Research Consortium (VARC) three guidelines. The outcomes of TF-TAVI procedures with Vascular Surgeons involvement were assessed as study’s endpoints.

Results

Overall, 937 TAVI procedures were performed with a TF approach ranging between 78% (2016) and 98% (2020). Vascular Surgeons were involved in 67 (7%) procedures with the following indications: concomitant abdominal aortic aneurysm (EVAR + TAVI) - 3 (4%), carotid stenosis (TAVI + CAS) - 2 (3%), hostile femoral/iliac access, or VACs - 62 (93%). Balloon angioplasty of iliac artery pre-TAVI implantation was performed in 51 cases (conventional PTA: 38/51%–75%; conventional PTA + intravascular lithotripsy: 13/51%–25%; stenting: 5/51%–10%). TAVI procedure was successfully completed by percutaneous TF approach in all 62 cases with challenging femoral/iliac access. VACs necessitating interventions were 18/937 (2%) cases, localized to the common femoral or common/external iliac artery in 15/18 (83%) and 3/18 (17%) cases, respectively. They were managed by surgical or endovascular maneuvers in 3/18 (17%) and 15/18 (83%) cases, respectively. Fifteen/18 (83%) VACs were treated during the index procedure. There was no procedure-related mortality or 30-day readmission.

Conclusion

In our experience, Vascular Surgeon assistance in TAVI procedures was not infrequent and allowed safe and effective device introduction through challenging TF access. Similarly, the concomitant significant disease of other vascular districts could be safely addressed, potentially reducing postoperative related mortality and morbidity. The implementation of multidisciplinary team with interventional cardiologists and vascular surgeons should be encouraged whenever possible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementAortic Valve StenosisSurgeonsFemoral ArteryCatheterization, PeripheralPhysician's RoleAortic ValveHumansRetrospective StudiesMaleTreatment OutcomeFemaleAged, 80 and overAgedRisk FactorsTime FactorsPatient Care TeamPostoperative ComplicationsPuncturesRisk Assessment

Stichwörter der Autor:innen

Transcatheter aortic valve implantatioendovascular repairtransfemoralvascular access complicationsvascular surgery

Autor:innen und Institutionen

  • Vascular Surgery, Department of Experimental, Diagnostic and Specialty Medicine, IRCCS Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
  • Division of Interventional Cardiology, IRCCS Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

ORCID-Profile: Enrico Gallitto, Rodolfo Pini, Francesca Maria Feroldi

Zitieren

APA

Gallitto, E., Faggioli, G., Saia, F., Palmerini, T., Pini, R., Bruno, A. G., Feroldi, F. M., Alaidroos, M., Ghetti, G., Taglieri, N., Caputo, S., Donati, F., Marrozzini, C., & Gargiulo, M. (2025). The role of the vascular surgeon in transcatheter aortic valve implantation. Vascular. https://doi.org/10.1177/17085381241237844

Vancouver

Gallitto E, Faggioli G, Saia F, Palmerini T, Pini R, Bruno AG, et al. The role of the vascular surgeon in transcatheter aortic valve implantation. Vascular. 2025. doi:10.1177/17085381241237844

BibTeX
@article{Gallitto2025,
  author = {Gallitto, Enrico and Faggioli, Gianluca and Saia, Francesco and Palmerini, Tullio and Pini, Rodolfo and Bruno, Antonio Giulio and Feroldi, Francesca Maria and Alaidroos, Moad and Ghetti, Gabriele and Taglieri, Nevio and Caputo, Stefania and Donati, Francesco and Marrozzini, Cinzia and Gargiulo, Mauro},
  title = {The role of the vascular surgeon in transcatheter aortic valve implantation},
  journal = {Vascular},
  year = {2025},
  doi = {10.1177/17085381241237844}
}
Kostenlos starten →